Literature DB >> 23625390

Affinity depletion of plasma and serum for mass spectrometry-based proteome analysis.

Julian A J Jaros1, Paul C Guest, Sabine Bahn, Daniel Martins-de-Souza.   

Abstract

Protein biomarker discovery in blood plasma and serum is severely hampered by the vast dynamic range of the proteome. With protein concentrations spanning 12 orders of magnitude, conventional mass spectrometric analysis allows for detection of only a few low-abundance proteins. Prior depletion of high-abundant proteins from the sample can increase analytical depth considerably and has become a widely used practice. We describe in detail an affinity depletion method that selectively removes 14 of the most abundant proteins in plasma and serum.

Mesh:

Substances:

Year:  2013        PMID: 23625390     DOI: 10.1007/978-1-62703-360-2_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Molecular serum signature of treatment resistant depression.

Authors:  Tillmann Ruland; Man K Chan; Pawel Stocki; Laura Grosse; Matthias Rothermundt; Jason D Cooper; Volker Arolt; Sabine Bahn
Journal:  Psychopharmacology (Berl)       Date:  2016-06-20       Impact factor: 4.530

2.  Human Blood Plasma Investigation Employing 2D UPLC-UDMSE Data-Independent Acquisition Proteomics.

Authors:  Licia C Silva-Costa; Bradley J Smith; Pamela T Carlson; Gustavo H M F Souza; Daniel Martins-de-Souza
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.

Authors:  Carol Chase Huizar; Itay Raphael; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2020-09-20       Impact factor: 4.868

4.  Paper-based cascade cationic isotachophoresis: Multiplex detection of cardiac markers.

Authors:  Shuang Guo; William Schlecht; Lei Li; Wen-Ji Dong
Journal:  Talanta       Date:  2019-07-02       Impact factor: 6.057

Review 5.  Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.

Authors:  Itay Raphael; Johanna Webb; Olaf Stuve; William Haskins; Thomas Forsthuber
Journal:  Expert Rev Clin Immunol       Date:  2014-12-18       Impact factor: 4.473

Review 6.  Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluids.

Authors:  Chaochao Wu; Jicheng Duan; Tao Liu; Richard D Smith; Wei-Jun Qian
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-01-12       Impact factor: 3.205

7.  Microwave & magnetic (M2) proteomics reveals CNS-specific protein expression waves that precede clinical symptoms of experimental autoimmune encephalomyelitis.

Authors:  Itay Raphael; Swetha Mahesula; Anjali Purkar; David Black; Alexis Catala; Jonathon A L Gelfond; Thomas G Forsthuber; William E Haskins
Journal:  Sci Rep       Date:  2014-09-03       Impact factor: 4.379

8.  Optimizing Human Bile Preparation for Two-Dimensional Gel Electrophoresis.

Authors:  Hao-Tsai Cheng; Sen-Yung Hsieh; Chang-Mu Sung; Betty Chien-Jung Pai; Nai-Jen Liu; Carl P C Chen
Journal:  Biomed Res Int       Date:  2016-02-04       Impact factor: 3.411

9.  Biological pathways modulated by antipsychotics in the blood plasma of schizophrenia patients and their association to a clinical response.

Authors:  Daniel Martins-de-Souza; Fiorella A Solari; Paul C Guest; René P Zahedi; Johann Steiner
Journal:  NPJ Schizophr       Date:  2015-12-09

Review 10.  Proteomics Landscape of Alzheimer's Disease.

Authors:  Ankit P Jain; Gajanan Sathe
Journal:  Proteomes       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.